Vivos therapeutics schedules release of fourth quarter and full year 2023 financial results and conference call

Littleton, colo., march 28, 2024 (globe newswire) -- vivos therapeutics, inc. (“vivos” or the “company”) (nasdaq: vvos), a leading medical device and technology company specializing in the development and commercialization of highly effective proprietary treatments for sleep related breathing disorders (including all severities of obstructive sleep apnea (osa in adults)), today announced it plans to release its fourth quarter and full year 2023 financial results after market close today, thursday, march 28, 2024.
VVOS Ratings Summary
VVOS Quant Ranking